|
Real-time
CBOE
09:00:00 26/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 49.15 EUR | +0.11% |
|
+0.80% | +32.71% |
| 25/08 | Bayer Group Receives Approval For Sevabertinib In Japan For HER2-Mutant Non-Small Cell Lung Cancer | CI |
| 24/08 | CAC 40 pauses ahead of Nvidia and Jackson Hole |
Chart: Technical Analysis
Stock exchange
CBOE
BAYNd 49.15 €
+0.11%
4.19Cr
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Xetra
| BAYN | 49.19EUR | -0.14% | 4.35Cr € | |
CBOE
| BAYNd | 49.15EUR | +0.11% | 4.19Cr € | |
Tradegate
| BAYN | 49.17EUR | -0.06% | 62.1L € | |
Boerse Muenchen
| BAYN | 49.01EUR | -0.79% | 48.61L € | |
Borsa Italiana
| 1BAYN | 49.14EUR | +1.30% | 7L € | |
Börse Stuttgart
| BAYN | 49.19EUR | +0.14% | 5L € | |
Wiener Boerse
| BAYN | 49.10EUR | 0.00% | 74.88T € | |
Deutsche Boerse AG
| BAYN | 49.39EUR | +0.59% | 59.27T € | |
London S.E.
| BYR | 49.69EUR | +1.06% | 51.33T € | |
Bulgaria S.E.
| BAYN | 48.41EUR | +1.64% | 33.84T € | |
OTC Markets
| BAYZF | 57.35USD | 0.00% | 28.68T $ | |
Budapest S.E.
| BAYER | 17,685.00HUF | -1.20% | 8L Ft | |
Warsaw S.E.
| BAY | 210.50EUR | +1.84% | 4.21T € | |
Warsaw S.E.
| BAY | 210.50PLN | +1.84% | 4.21T zł | |
Swiss Exchange
| BAYN | 45.57CHF | -0.61% | 501.27 CHF | |
Mexican S.E.
| BAYN N | 912.16MXN | +17.09% | 5.47T $ | |
CBOE
| BYR | 47.96EUR | 0.00% | 0 € | |
OTC Markets
| BAYRY | 14.30USD | -0.26% | 14.48L $ | |
Deutsche Boerse AG
| BAYA | 12.40EUR | +5.08% | 471.2 € | |
Börse Stuttgart
| BAYA | 12.20EUR | 0.00% | 0 € | |
Boerse Muenchen
| BAYA | 12.30EUR | +0.82% | 0 € | |
Buenos Aires S.E.
| BAYN | 31,300.00ARS | +9.75% | 2.4Cr $ |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BAYN Stock
- BAYNd Stock
- Charts Bayer AG
Select your edition
All financial news and data tailored to specific country editions

















